During the past decade, IRCCS Istituto Delle Scienze Neurologiche di Bologna conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 9 clinical trials were completed, i.e. on average, 45% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 7 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IRCCS Istituto Delle Scienze Neurologiche di Bologna" #1 sponsor was "H. Lundbeck A/S" with 4 trials, followed by "Azienda Usl di Bologna" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "GenSight Biologics" with 2 trials sponsored and "Santhera Pharmaceuticals" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IRCCS Istituto Delle Scienze Neurologiche di Bologna" #1 collaborator was "Heidelberg University" with 1 trials as a collaborator, "Ministero della Salute, Italy" with 1 trials as a collaborator and "Mortara Instrument Europe S.r.l." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "IRCCS Istituto Delle Scienze Neurologiche di Bologna" are "Leber's Hereditary Optic Neuropathy (LHON)" (2 trials), "Migraine" (2 trials), "Optic, Atrophy, Hereditary, Leber" (2 trials), "Symptomatic Neurogenic Orthostatic Hypotension" (2 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "IRCCS Istituto Delle Scienze Neurologiche di Bologna" in a lesser frequency.

Most popular intervention types in "IRCCS Istituto Delle Scienze Neurologiche di Bologna" are "Drug" (14 trials), "Device" (3 trials), "Biological" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Eptinezumab" (3 trials), "GS010" (2 trials), "Idebenone" (2 trials) and "Sham Intravitreal Injection" (2 trials). Other intervention names were less common.

The vast majority of trials in "IRCCS Istituto Delle Scienze Neurologiche di Bologna" are 22 trials for "All" genders.

Currently, there are NaN active trials in "IRCCS Istituto Delle Scienze Neurologiche di Bologna". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in IRCCS Istituto Delle Scienze Neurologiche di Bologna, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in IRCCS Istituto Delle Scienze Neurologiche di Bologna, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".